Register for our latest webinar series to learn how AI is being applied to all stages across the drug discovery […]
Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
Despite an increase in investment into R&D from biopharma companies, only 5-10% of drugs that enter early-stage clinical trials ever […]
The drug discovery process can be long and gruelling, but when backed by genetic evidence, drugs are twice as likely […]
Only 10% of new molecular entities that are in early clinical trials ever make it to approval. However, those with […]
Over 50 million people worldwide are currently living with epilepsy. However, one third of patients are resistant to common antiseizure […]
‘Breaking bonds: a new enzyme to help drug discovery’ – Written by Charlotte Harrison, Science Writer. Amide bonds are strong […]
In a recent paper published in Science Advances, a research team has developed a twin-bioengine yeast nanorobot for gastro-intestinal (GI) […]
Researchers have developed an antibacterial compound that is effective against multidrug resistant bacteria. The study, published in Nature Communications, combined […]
The COVID-19 pandemic was controlled due to the rapid development of new vaccines and anti-viral drugs. However, the emergence of […]
